Recombinant Human EAAT5 Protein，His

EAAT5 (excitatory amino acid transporter 5) is a member of the glutamate transporter family, predominantly expressed in the retina and certain regions of the brain. It plays a crucial role in clearing glutamate from the synaptic cleft, thereby preventing excitotoxicity and maintaining synaptic homeostasis. The dysfunction of EAAT5 has been implicated in various neurological disorders, including retinal diseases and neurodegenerative conditions, where impaired glutamate clearance leads to neuronal damage. Given its importance in neurotransmission and neuroprotection, researchers have focused on the characterization and functional analysis of EAAT5, particularly through the generation of recombinant proteins. These recombinant proteins allow for the investigation of EAAT5's structural and functional properties, facilitating studies on its substrate specificity, ion dependence, and regulatory mechanisms. Understanding the pharmacological properties of EAAT5 may lead to the development of targeted therapies for diseases associated with glutamate dysregulation. Furthermore, EAAT5 serves as a valuable model for studying the transport mechanisms of excitatory amino acids, providing insights into the broader transport systems within the central nervous system. As research progresses, the application of recombinant EAAT5 proteins in drug testing and potential therapeutic interventions underscores the relevance of this transporter in both basic neuroscience and clinical contexts.